- Home
- ALMS vs BNTC Comparison
ALMS vs BNTC Comparison
Compare ALMS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- BNTC
- Stock Information
- Founded
- ALMS 2021
- BNTC 1995
- Country
- ALMS United States
- BNTC United States
- Employees
- ALMS N/A
- BNTC N/A
- Industry
- ALMS
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ALMS
- BNTC Health Care
- Exchange
- ALMS NYSE
- BNTC Nasdaq
- Market Cap
- ALMS 402.6M
- BNTC 335.5M
- IPO Year
- ALMS 2024
- BNTC N/A
- Fundamental
- Price
- ALMS $4.10
- BNTC $11.25
- Analyst Decision
- ALMS Strong Buy
- BNTC Strong Buy
- Analyst Count
- ALMS 6
- BNTC 5
- Target Price
- ALMS $19.80
- BNTC $26.00
- AVG Volume (30 Days)
- ALMS 692.8K
- BNTC 86.1K
- Earning Date
- ALMS 08-12-2025
- BNTC 05-14-2025
- Dividend Yield
- ALMS N/A
- BNTC N/A
- EPS Growth
- ALMS N/A
- BNTC N/A
- EPS
- ALMS N/A
- BNTC N/A
- Revenue
- ALMS $17,389,000.00
- BNTC N/A
- Revenue This Year
- ALMS N/A
- BNTC N/A
- Revenue Next Year
- ALMS N/A
- BNTC N/A
- P/E Ratio
- ALMS N/A
- BNTC N/A
- Revenue Growth
- ALMS N/A
- BNTC N/A
- 52 Week Low
- ALMS $2.76
- BNTC $7.05
- 52 Week High
- ALMS $13.20
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- BNTC 39.86
- Support Level
- ALMS N/A
- BNTC $10.70
- Resistance Level
- ALMS N/A
- BNTC $12.26
- Average True Range (ATR)
- ALMS 0.00
- BNTC 0.83
- MACD
- ALMS 0.00
- BNTC -0.02
- Stochastic Oscillator
- ALMS 0.00
- BNTC 17.46
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.